Specific Treatment of Vaginal Trichomoniasis—But When?

Abstract

Metronidazole, an agent for oral treatment of vaginal trichomoniasis, represents a major breakthrough in management of this persistent and frustrating condition. The product has been tested by numerous clinical investigators in the United States but has not yet been released by the FDA for general use; it is anticipated that it will be released soon. It has been given to thousands of patients in France, Germany, Great Britain and Canada and has been highly effective.